Global Next Generation Cancer Diagnostics Market Analysis 2017-2021 and Forecast 2021-2027

  • Published Date : 24-11-2021
  • Pages : 103
  • Report Id : 31043
  • Categories : Healthcare



The global Next Generation Cancer Diagnostics market size is estimated at xxx million USD with a CAGR xx% from 2017-2021 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2027. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Next Generation Cancer Diagnostics by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Next Generation Sequencing
qPCR & Multiplexing
DNA Microarrays
Others

Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
Cepheid
Koninklijke Philips N.V
F. Hoffmann-La Roche Ltd
Qiagen
Novartis AG
Abbott
Thermo Fisher Scientific
Opko Health
Myriad Genetics
Agilent Technologies
GE Healthcare
PerkinElmer
Genomic Health
Illumina
Hologic
Almac Group
Janssen Global Services
Sysmex Corporation

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Hospitals
Clinics
Others

Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)


Table of Contents
1 Industry Overview
1.1 Next Generation Cancer Diagnostics Industry
Figure Next Generation Cancer Diagnostics Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Next Generation Cancer Diagnostics
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Next Generation Cancer Diagnostics
1.2.2 Downstream
Table Application Segment of Next Generation Cancer Diagnostics
Table Global Next Generation Cancer Diagnostics Market 2017-2027, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Next Generation Cancer Diagnostics Market by Type
3.1 By Type
3.1.1 Next Generation Sequencing
Table Major Company List of Next Generation Sequencing
3.1.2 qPCR & Multiplexing
Table Major Company List of qPCR & Multiplexing
3.1.3 DNA Microarrays
Table Major Company List of DNA Microarrays
3.1.4 Others
Table Major Company List of Others
3.2 Market Size
Table Global Next Generation Cancer Diagnostics Market 2017-2021, by Type, in USD Million
Figure Global Next Generation Cancer Diagnostics Market Growth 2017-2021, by Type, in USD Million
Table Global Next Generation Cancer Diagnostics Market 2017-2021, by Type, in Volume
Figure Global Next Generation Cancer Diagnostics Market Growth 2017-2021, by Type, in Volume
3.3 Market Forecast
Table Global Next Generation Cancer Diagnostics Market Forecast 2021-2027, by Type, in USD Million
Table Global Next Generation Cancer Diagnostics Market Forecast 2021-2027, by Type, in Volume
4 Major Companies List
4.1 Cepheid (Company Profile, Sales Data etc.)
4.1.1 Cepheid Profile
Table Cepheid Overview List
4.1.2 Cepheid Products & Services
4.1.3 Cepheid Business Operation Conditions
Table Business Operation of Cepheid (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Koninklijke Philips N.V (Company Profile, Sales Data etc.)
4.2.1 Koninklijke Philips N.V Profile
Table Koninklijke Philips N.V Overview List
4.2.2 Koninklijke Philips N.V Products & Services
4.2.3 Koninklijke Philips N.V Business Operation Conditions
Table Business Operation of Koninklijke Philips N.V (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 F. Hoffmann-La Roche Ltd (Company Profile, Sales Data etc.)
4.3.1 F. Hoffmann-La Roche Ltd Profile
Table F. Hoffmann-La Roche Ltd Overview List
4.3.2 F. Hoffmann-La Roche Ltd Products & Services
4.3.3 F. Hoffmann-La Roche Ltd Business Operation Conditions
Table Business Operation of F. Hoffmann-La Roche Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Qiagen (Company Profile, Sales Data etc.)
4.4.1 Qiagen Profile
Table Qiagen Overview List
4.4.2 Qiagen Products & Services
4.4.3 Qiagen Business Operation Conditions
Table Business Operation of Qiagen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Novartis AG (Company Profile, Sales Data etc.)
4.5.1 Novartis AG Profile
Table Novartis AG Overview List
4.5.2 Novartis AG Products & Services
4.5.3 Novartis AG Business Operation Conditions
Table Business Operation of Novartis AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Abbott (Company Profile, Sales Data etc.)
4.6.1 Abbott Profile
Table Abbott Overview List
4.6.2 Abbott Products & Services
4.6.3 Abbott Business Operation Conditions
Table Business Operation of Abbott (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Thermo Fisher Scientific (Company Profile, Sales Data etc.)
4.7.1 Thermo Fisher Scientific Profile
Table Thermo Fisher Scientific Overview List
4.7.2 Thermo Fisher Scientific Products & Services
4.7.3 Thermo Fisher Scientific Business Operation Conditions
Table Business Operation of Thermo Fisher Scientific (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 Opko Health (Company Profile, Sales Data etc.)
4.8.1 Opko Health Profile
Table Opko Health Overview List
4.8.2 Opko Health Products & Services
4.8.3 Opko Health Business Operation Conditions
Table Business Operation of Opko Health (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 Myriad Genetics (Company Profile, Sales Data etc.)
4.9.1 Myriad Genetics Profile
Table Myriad Genetics Overview List
4.9.2 Myriad Genetics Products & Services
4.9.3 Myriad Genetics Business Operation Conditions
Table Business Operation of Myriad Genetics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 Agilent Technologies (Company Profile, Sales Data etc.)
4.10.1 Agilent Technologies Profile
Table Agilent Technologies Overview List
4.10.2 Agilent Technologies Products & Services
4.10.3 Agilent Technologies Business Operation Conditions
Table Business Operation of Agilent Technologies (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.11 GE Healthcare (Company Profile, Sales Data etc.)
4.11.1 GE Healthcare Profile
Table GE Healthcare Overview List
4.11.2 GE Healthcare Products & Services
4.11.3 GE Healthcare Business Operation Conditions
Table Business Operation of GE Healthcare (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.12 PerkinElmer (Company Profile, Sales Data etc.)
4.12.1 PerkinElmer Profile
Table PerkinElmer Overview List
4.12.2 PerkinElmer Products & Services
4.12.3 PerkinElmer Business Operation Conditions
Table Business Operation of PerkinElmer (Sales Revenue, Cost, Gross Margin)
4.13 Genomic Health (Company Profile, Sales Data etc.)
4.13.1 Genomic Health Profile
Table Genomic Health Overview List
4.13.2 Genomic Health Products & Services
4.13.3 Genomic Health Business Operation Conditions
Table Business Operation of Genomic Health (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.14 Illumina (Company Profile, Sales Data etc.)
4.14.1 Illumina Profile
Table Illumina Overview List
4.14.2 Illumina Products & Services
4.14.3 Illumina Business Operation Conditions
Table Business Operation of Illumina (Sales Revenue, Cost, Gross Margin)
4.15 Hologic (Company Profile, Sales Data etc.)
4.15.1 Hologic Profile
Table Hologic Overview List
4.15.2 Hologic Products & Services
4.15.3 Hologic Business Operation Conditions
Table Business Operation of Hologic (Sales Revenue, Cost, Gross Margin)
4.16 Almac Group (Company Profile, Sales Data etc.)
4.16.1 Almac Group Profile
Table Almac Group Overview List
4.16.2 Almac Group Products & Services
4.16.3 Almac Group Business Operation Conditions
Table Business Operation of Almac Group (Sales Revenue, Cost, Gross Margin)
4.17 Janssen Global Services (Company Profile, Sales Data etc.)
4.17.1 Janssen Global Services Profile
Table Janssen Global Services Overview List
4.17.2 Janssen Global Services Products & Services
4.17.3 Janssen Global Services Business Operation Conditions
Table Business Operation of Janssen Global Services (Sales Revenue, Cost, Gross Margin)
4.18 Sysmex Corporation (Company Profile, Sales Data etc.)
4.18.1 Sysmex Corporation Profile
Table Sysmex Corporation Overview List
4.18.2 Sysmex Corporation Products & Services
4.18.3 Sysmex Corporation Business Operation Conditions
Table Business Operation of Sysmex Corporation (Sales Revenue, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Next Generation Cancer Diagnostics Sales Revenue 2017-2021, by Company, in USD Million
Table Global Next Generation Cancer Diagnostics Sales Revenue Share 2017-2021, by Company, in USD Million
Figure Global Next Generation Cancer Diagnostics Sales Revenue Share in 2021, by Company, in USD Million
Table Global Next Generation Cancer Diagnostics Sales Volume 2017-2021, by Company, in Volume
Table Global Next Generation Cancer Diagnostics Sales Volume Share 2017-2021, by Company, in Volume
Figure Global Next Generation Cancer Diagnostics Sales Volume Share in 2021, by Company, in Volume
5.2 Regional Market by Company
Figure North America Next Generation Cancer Diagnostics Market Concentration, in 2021
Figure Europe Next Generation Cancer Diagnostics Market Market Concentration, in 2021
Figure Asia-Pacific Next Generation Cancer Diagnostics MMarket Concentration, in 2021
Figure South America Next Generation Cancer Diagnostics Market Concentration, in 2021
Figure Middle East & Africa Next Generation Cancer Diagnostics Market Concentration, in 2021
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Hospitals
Figure Next Generation Cancer Diagnostics Demand in Hospitals, 2017-2021, in USD Million
Figure Next Generation Cancer Diagnostics Demand in Hospitals, 2017-2021, in Volume
6.1.2 Demand in Clinics
Figure Next Generation Cancer Diagnostics Demand in Clinics, 2017-2021, in USD Million
Figure Next Generation Cancer Diagnostics Demand in Clinics, 2017-2021, in Volume
6.1.3 Demand in Others
Figure Next Generation Cancer Diagnostics Demand in Others, 2017-2021, in USD Million
Figure Next Generation Cancer Diagnostics Demand in Others, 2017-2021, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Next Generation Cancer Diagnostics Demand Forecast 2021-2027, by Application, in USD Million
Figure Next Generation Cancer Diagnostics Market Growth 2021-2027, by Application, in USD Million
Figure Next Generation Cancer Diagnostics Market Share in 2027, by Application, in USD Million
Table Next Generation Cancer Diagnostics Demand Forecast 2021-2027, by Application, in Volume
Table Next Generation Cancer Diagnostics Market Growth 2021-2027, by Application, in Volume
Table Next Generation Cancer Diagnostics Market Share in 2027, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand
7 Region Operation
7.1 Regional Production
Table Next Generation Cancer Diagnostics Production 2017-2021, by Region, in USD Million
Table Next Generation Cancer Diagnostics Production 2017-2021, by Region, in Volume
7.2 Regional Market
Table Global Next Generation Cancer Diagnostics Market 2017-2021, by Region, in USD Million
Table Global Next Generation Cancer Diagnostics Market Share 2017-2021, by Region, in USD Million
Table Global Next Generation Cancer Diagnostics Market 2017-2021, by Region, in Volume
Table Global Next Generation Cancer Diagnostics Market Share 2017-2021, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Next Generation Cancer Diagnostics Market Size and Growth 2017-2021, in USD Million
Figure North America Next Generation Cancer Diagnostics Market Size and Growth 2017-2021, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Next Generation Cancer Diagnostics Market Size 2017-2021, by Country, in USD Million
Table North America Next Generation Cancer Diagnostics Market Size 2017-2021, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Next Generation Cancer Diagnostics Market Size and Growth 2017-2021, in USD Million
Figure Europe Next Generation Cancer Diagnostics Market Size and Growth 2017-2021, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Next Generation Cancer Diagnostics Market Size 2017-2021, by Country, in USD Million
Table Europe Next Generation Cancer Diagnostics Market Size 2017-2021, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Next Generation Cancer Diagnostics Market Size and Growth 2017-2021, in USD Million
Figure Asia-Pacific Next Generation Cancer Diagnostics Market Size and Growth 2017-2021, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Next Generation Cancer Diagnostics Market Size 2017-2021, by Country, in USD Million
Table Asia-Pacific Next Generation Cancer Diagnostics Market Size 2017-2021, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Next Generation Cancer Diagnostics Market Size and Growth 2017-2021, in USD Million
Figure South America Next Generation Cancer Diagnostics Market Size and Growth 2017-2021, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Next Generation Cancer Diagnostics Market Size 2017-2021, by Country, in USD Million
Table South America Next Generation Cancer Diagnostics Market Size 2017-2021, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Next Generation Cancer Diagnostics Market Size and Growth 2017-2021, in USD Million
Figure Middle East & Africa Next Generation Cancer Diagnostics Market Size and Growth 2017-2021, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Next Generation Cancer Diagnostics Market Size 2017-2021, by Country, in USD Million
Table Middle East & Africa Next Generation Cancer Diagnostics Market Size 2017-2021, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Next Generation Cancer Diagnostics Market Forecast 2021-2027, by Region, in USD Million
Table Next Generation Cancer Diagnostics Market Forecast 2021-2027, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion

Direct Purchase
Your perfect start with Stats And Research


Want to customize this report?

This report can be customized according to your requirements. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

We offer $1000 worth of FREE customization at the time of purchase.
RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo

You may also be lnterested in..

Stats And Research Copyright © 2022 .